My Health Day by Day (Mi Salud Dia a Dia)

Sponsor
University of Miami (Other)
Overall Status
Recruiting
CT.gov ID
NCT04545021
Collaborator
National Cancer Institute (NCI) (NIH)
240
1
39.7
6

Study Details

Study Description

Brief Summary

The purpose of this study is to is to evaluate how Cognitive Behavioral Stress Management (CBSM) targets (e.g., anxiety reduction, cognitive reappraisal, coping, emotional expression, communication skills, social support) operate through Science of Behavior Change (SOBC) measures and influence dyadic adjustment and Health Related Quality of Life (HRQoL) in Prostate Cancer (PC) survivors and spouses/partners, in addition to physiologic adaptation and symptom burden in PC survivors.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    240 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Multilevel and Ecologically Grounded Assessments of Personality, Emotions and Self- Regulation as Determinants of Psychological and Physiological Adaptation in Latino Prostate Cancer Survivors Undergoing Stress Management Training
    Actual Study Start Date :
    Oct 11, 2019
    Anticipated Primary Completion Date :
    Oct 11, 2022
    Anticipated Study Completion Date :
    Jan 31, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Cognitive Behavioral Stress Management (CBSM) - PC Survivor

    Participant receives standard cognitive behavioral stress management from the Parent study NCT03344757.

    CBSM - PC Survivor Partner

    The survivor partner does not receive any intervention.

    Cultural CBSM (C-CBSM) - PC Survivor

    Participant receives culturally adapted cognitive behavioral stress management from the Parent study NCT03344757.

    Cultural CBSM (C-CBSM) - PC Survivor Partner

    The survivor partner does not receive any intervention.

    Outcome Measures

    Primary Outcome Measures

    1. Change in emotion regulation [Baseline to month 4, baseline to month 6]

      Change in emotion regulation will be measured using the Emotion Regulation Questionnaire (ERQ). ERQ is a 10-item questionnaire with a total score ranging from 0-70 with the higher score indicating greater use of emotional regulation strategy.

    2. Change in self regulation [Baseline to month 4, baseline to month 6]

      Change in self-regulation will be measured using the Short Self-Regulation Questionnaire (SSRQ). The SSRQ is a 31-item self-report questionnaire with a total score ranging from 30-150 with the higher score indicating greater self-regulation.

    3. Change in mindfulness attention awareness [Baseline to month 4, baseline to month 6]

      Change in mindfulness attention awareness is measured using the Mindfulness Attention Awareness Scale (MAAS). MAAS has 15 questions with a total score ranging from 15-90 with the higher score indicating higher levels of dispositional mindfulness

    4. Change in couple coercion [Baseline to month 4, baseline to month 6]

      Change in couple coercion is measured using the Couple Coercion Questionnaire (CCQ). The CCQ is a 12 item questionnaire with the total score ranging from 12-72, with the higher score indicating increased perception of how coercion exemplifies his/her relationship with his/her partner.

    5. Change in behavioral inhibition [Baseline to month 4, baseline to month 6]

      Behavioral Inhibition is measured using the Behavioral Inhibition and Activation Scale (BIS/BAS). BIS/BAS scale is a 24-item questionnaire with the BIS composing of items 2, 8, 13, 16, 19, 22 and 24. The total score for BIS has a range of 7-28 with the higher score indicating increase avoidance of aversive outcomes.

    6. Change in behavioral activation [Baseline to month 4, baseline to month 6]

      Behavioral Activation is measured using the Behavioral Inhibition and Activation Scale (BIS/BAS). BIS/BAS scale is a 24-item questionnaire with the BAS composing of a subset of questions with a total score ranging from of 13-52 with the higher score indicating increased motivation to approach goal-oriented outcomes.

    7. Change in relationship satisfaction [Baseline to month 4, baseline to month 6]

      Changes in relationship satisfaction as assessed by the Revised Dyadic Adjustment Scale (RDAS). RDAS is a 14-item measure with total scores ranging from 0-69 with the higher scores indicate greater relationship satisfaction.

    8. Heart rate variability [Up to Month 6]

      Heart rate variability collected via the Empatica wrist watch

    9. Electrodermal activity [Up to Month 6]

      Electrodermal activity collected via the Empatica wrist watch

    10. Life satisfaction as measured by the Affective Balance Scale (ABS) [Up to Month 6]

      ABS is 10 item questionnaire with a total score ranging from 0-5, with the higher score indicating higher life satisfaction.

    11. Measure of Current Status (MOCS) [Up to Month 6]

      The MOCS questionnaire has a total score ranging from 0-52 with the higher score indicating increased likelihood of having the ability to relax at will.

    12. Level of stress [Up to Month 6]

      Level of stress will be measured using a Likert Scale question ranging from 1-4 with the higher value indicating greater stress.

    13. Frequency of Text messages [Month 6]

      The frequency of text messages will be reported as total amount of text messages sent and received per month, collected via Short Messaging Service (SMS) extraction software.

    14. Length of Text messages [Month 6]

      The length of text messages will be reported as average number of lines per text message collected via SMS extraction software

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    Prostate Cancer Survivor

    1. ≥18 years of age

    2. Hispanic/Latino self- identification

    3. Spanish speakers (including bilinguals who agree to participate in a Spanish intervention)

    4. primary diagnosis of localized PC (T1-T3, N0, M0)

    5. surgical or radiation treatment in the past 4-months

    6. no history of non-skin cancer for the past 2 years

    7. no psychiatric treatment or overt signs of severe psychopathology (e.g., psychosis, substance dependence)

    8. owning a smartphone device with an Android or iPhone Operating System (iOS), which is necessary to collect the proposed Ecological Momentary Assessment (EMA) data or a valid email address.

    (I) willingness to wear the E4 wristband at 5 time points, over the course of 4 days (J) has a spouse/partner that is willing to participate or is willing to participate in the study alone

    Spouses/Partners:
    1. female or male ≥18 years of age

    2. have no history of inpatient psychiatric treatment for severe mental illness or overt signs of severe psychopathology (e.g., psychosis, substance dep., dementia)

    3. willingness to be assessed and followed for 6 months

    4. no life-threatening illness with a life expectancy < 12 months

    5. identifies as a spouse/partner and is willing to participate in the study.

    Exclusion Criteria:
    • Not meeting all of the inclusion criteria

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Miami Miami Florida United States 33136

    Sponsors and Collaborators

    • University of Miami
    • National Cancer Institute (NCI)

    Investigators

    • Principal Investigator: Frank Penedo, Ph.D., University of Miami

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Frank Penedo, Professor, University of Miami
    ClinicalTrials.gov Identifier:
    NCT04545021
    Other Study ID Numbers:
    • 20190613
    • 1R01CA206456-01A1
    First Posted:
    Sep 10, 2020
    Last Update Posted:
    Dec 3, 2021
    Last Verified:
    Dec 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Frank Penedo, Professor, University of Miami

    Study Results

    No Results Posted as of Dec 3, 2021